Erasca, Inc. - Common Stock, $0.0001 par value per share (ERAS) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
ERAS on Nasdaq
Shares outstanding
286,020,660
Price per share
$3.72
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
214,973,660
Total reported value
$468,652,318
% of total 13F portfolios
0%
Share change
-3,194,808
Value change
-$3,517,116
Number of holders
139
Price from insider filings
$3.72
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Erasca, Inc. - Common Stock, $0.0001 par value per share (ERAS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 7.2% $28,871,669 20,332,161 T. Rowe Price Investment Management, Inc. 30 Jun 2025
Paradigm Biocapital Advisors LP 5.3% $56,391,833 15,159,095 Paradigm BioCapital Advisors LP 07 Jan 2026
Frazier Life Sciences Public Fund, L.P. 5.3% -34% $21,355,029 -$10,702,679 15,038,753 -33% Frazier Life Sciences Public Fund, L.P. 30 Jun 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 5.1% +18% $20,592,846 +$3,105,540 14,502,004 +18% Suvretta Capital Management, LLC 30 Jun 2025
Logos Global Management LP 4.8% -10% $29,648,000 -$3,270,000 13,600,000 -9.9% Logos Global Management LP 30 Sep 2025
NOVARTIS PHARMA AG 4.4% $17,107,692 12,307,692 Novartis Pharma AG 31 Dec 2024

As of 30 Sep 2025, 139 institutional investors reported holding 214,973,660 shares of Erasca, Inc. - Common Stock, $0.0001 par value per share (ERAS). This represents 75% of the company’s total 286,020,660 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Erasca, Inc. - Common Stock, $0.0001 par value per share (ERAS) together control 70% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Frazier Life Sciences Management, L.P. 7.9% 22,729,436 0% 1.5% $49,550,170
T. Rowe Price Investment Management, Inc. 7.1% 20,231,906 -0.49% 0.03% $44,106,000
VR ADVISER, LLC 6.2% 17,857,083 0% 2.2% $38,928,441
Logos Global Management LP 5.3% 15,150,000 +1% 3.3% $33,027,000
BlackRock, Inc. 5.3% 15,071,319 -0.63% 0% $32,855,475
SUVRETTA CAPITAL MANAGEMENT, LLC 5.1% 14,502,004 0% 0.96% $31,614,369
Paradigm Biocapital Advisors LP 4.7% 13,560,017 +14% 0.87% $29,560,837
VANGUARD GROUP INC 4.5% 12,811,832 +0.92% 0% $27,929,793
ARCH Venture Management, LLC 3.9% 11,055,554 0% 4.9% $24,101,108
Vivo Capital, LLC 3.2% 9,273,428 +37% 1.6% $20,216,073
Siren, L.L.C. 3.1% 8,757,249 0% 0.75% $19,090,803
5AM Venture Management, LLC 1.9% 5,405,404 0% 4.3% $11,783,781
GEODE CAPITAL MANAGEMENT, LLC 1.7% 4,848,563 +0.27% 0% $10,572,627
Affinity Asset Advisors, LLC 1.5% 4,285,787 +4.9% 0.87% $9,343,016
STATE STREET CORP 1.4% 4,029,256 +0.68% 0% $8,783,778
MILLENNIUM MANAGEMENT LLC 1% 2,914,819 -23% 0.01% $6,354,305
a16z Capital Management, L.L.C. 1% 2,862,500 0% 0.45% $6,240,250
GOLDMAN SACHS GROUP INC 0.88% 2,517,188 +38% 0% $5,487,470
Soleus Capital Management, L.P. 0.76% 2,162,162 0% 0.25% $4,713,513
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.6% 1,725,356 +1.7% 0% $3,761,276
Woodline Partners LP 0.54% 1,534,390 -26% 0.02% $3,344,970
BANK OF AMERICA CORP /DE/ 0.54% 1,534,274 -2.4% 0% $3,344,718
TANG CAPITAL MANAGEMENT LLC 0.53% 1,502,915 0% 0.13% $3,276,355
NORTHERN TRUST CORP 0.5% 1,443,511 +2.3% 0% $3,146,854
DIMENSIONAL FUND ADVISORS LP 0.48% 1,371,935 -19% 0% $2,989,499

Institutional Holders of Erasca, Inc. - Common Stock, $0.0001 par value per share (ERAS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 107,826 $399,010 +$166,706 $3.72 8
2025 Q3 214,973,660 $468,652,318 -$3,517,116 $2.18 139
2025 Q2 218,177,770 $277,145,224 -$8,196,772 $1.27 141
2025 Q1 224,275,876 $307,274,963 -$9,730,312 $1.37 151
2024 Q4 230,866,824 $579,481,287 -$3,886,798 $2.51 144
2024 Q3 232,039,374 $633,439,326 +$46,910,487 $2.73 130
2024 Q2 203,567,396 $480,459,612 +$311,839,926 $2.36 124
2024 Q1 72,681,232 $149,721,765 +$6,866,672 $2.06 105
2023 Q4 69,247,665 $147,523,921 -$3,989,593 $2.13 115
2023 Q3 71,279,487 $140,403,646 -$6,391,863 $1.97 106
2023 Q2 74,333,071 $205,158,369 -$10,901,012 $2.76 110
2023 Q1 78,047,305 $234,907,735 -$11,497,274 $3.01 115
2022 Q4 79,824,946 $344,037,900 +$2,800,974 $4.31 106
2022 Q3 80,523,466 $628,084,382 +$33,781,376 $7.80 87
2022 Q2 76,887,302 $428,260,749 +$21,982,237 $5.57 87
2022 Q1 72,825,959 $626,627,487 +$45,427,981 $8.60 80
2021 Q4 63,677,801 $987,988,866 +$64,674,674 $15.58 63
2021 Q3 44,137,190 $918,521,616 +$918,521,616 $21.22 53